Covista (CVSA) Cost of Revenue (2009 - 2026)

Covista (CVSA) has 18 years of Cost of Revenue data on file, last reported at $210.7 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $210.7 million, up 5.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $815.8 million (up 8.05% YoY), and the FY2025 annual result was $771.4 million, up 10.43% from the prior year.
• Cost of Revenue rose to $210.7 million in Q1 2026 per CVSA's latest filing, from $205.4 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $210.7 million in Q1 2026 and troughed at $159.3 million in Q4 2022.
• A 5-year average of $180.2 million and a median of $175.3 million in 2024 frame the typical range for Cost of Revenue.
• On a YoY basis, Cost of Revenue climbed as much as 44.4% in 2022 and fell as far as 11.7% in 2022.
• A 5-year view of Cost of Revenue shows it stood at $159.3 million in 2022, then advanced by 8.01% to $172.1 million in 2023, then gained by 8.47% to $186.6 million in 2024, then climbed by 10.07% to $205.4 million in 2025, then gained by 2.58% to $210.7 million in 2026.
• Business Quant data shows CVSA's Cost of Revenue at $210.7 million in Q1 2026, $205.4 million in Q4 2025, and $200.8 million in Q3 2025.